Journal of Neural Transmission

, 114:1023

Prevalence and treatment strategies of dyskinesia in patients with Parkinson’s disease

  • T. Müller
  • D. Woitalla
  • H. Russ
  • K. Hock
  • D. A. Haeger
Short communication

DOI: 10.1007/s00702-007-0718-4

Cite this article as:
Müller, T., Woitalla, D., Russ, H. et al. J Neural Transm (2007) 114: 1023. doi:10.1007/s00702-007-0718-4

Summary

A study into the prevalence and treatment of dyskinesia in Parkinson’s disease (PD) patients was performed with 380 PD specialists-completed interviews relating to PD and retrospectively completed 1900 patient record forms for patients with dyskinesia. Physicians reported, that 34% of their PD patients experience dyskinesia, 57% of dyskinetic PD patients were affected by moderately-to-completely disabling dyskinesia. Treatment of dyskinesia was looked upon as not satisfactory, fractionating of levodopa dose was used as first choice therapeutic option of dyskinesia.

Keywords: Parkinson’s disease, dyskinesia, levodopa, patient disability, physician satisfaction 

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • T. Müller
    • 1
  • D. Woitalla
    • 1
  • H. Russ
    • 2
  • K. Hock
    • 2
  • D. A. Haeger
    • 2
  1. 1.Department of Neurology, St Josef HospitalRuhr UniversityBochumGermany
  2. 2.Merck KGaADarmstadtGermany

Personalised recommendations